Report offers ways to address cybersecurity challenges posed by legacy medical devices
The Food and Drug Administration on Nov. 16 announced a new report from government contractor MITRE, Next Steps Toward Managing Legacy Medical Device Cybersecurity Risks. The FDA acknowledges that legacy medical devices—those that cannot be reasonably protected against current cybersecurity threats—can pose significant risks to the health care sector. Legacy devices were legally put on the market and may still be broadly in use. To address this important security issue, the FDA contracted with MITRE to outline practical approaches and recommendations that can further drive sector-wide legacy device cyber risk management efforts.
Related News Articles
Headline
The FBI Jan. 8 released an alert on evolving threat tactics by Kimsuky, a North Korean state-sponsored cyber threat group. As of last year, the group…
Headline
The Cybersecurity and Infrastructure Security Agency Dec. 11 released an update to its voluntary Cybersecurity Performance Goals, which includes measurable…
Headline
U.S. and international agencies are warning of potential cyberattacks on health care and other critical infrastructure from state-sponsored cyber actors in…
Headline
A critical, unauthenticated remote code execution vulnerability known as React2Shell has been added to the Cybersecurity and Infrastructure Security Agency’s…
Headline
The Food and Drug Administration announced Dec. 5 that it will launch the Technology-Enabled Meaningful Patient Outcomes for Digital Health Devices Pilot, or…
Headline
The FBI has public resources available to help prevent exploitation by cybercriminals, who use artificial intelligence for deception. An infographic by the FBI…